A genome-wide overexpression screen reveals Mycobacterium smegmatis growth inhibitors encoded by mycobacteriophage

Isabel Amaya1, Kaylia Edwards1, Bethany M Wise1

  • 1Center for the Advancement of Science Leadership and Culture, Howard Hughes Medical Institute, Chevy Chase, MD 20185, USA.

G3 (Bethesda, Md.)
|November 7, 2023
PubMed

Insights

Researchers screened 94 bacteriophage genes from the Hammy phage, discovering 24 gene products that inhibit Mycobacterium smegmatis growth. This reveals novel phage-encoded antimycobacterial functions and highlights the value of phage gene discovery.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Bacteriophages encode numerous genes with unknown functions, representing a reservoir of novel biological activities.
  • Understanding these gene products is crucial for deciphering phage-host interactions and discovering new bioactive molecules.

Purpose of the Study:

  • To construct and screen a plasmid-based overexpression library of Hammy mycobacteriophage genes.
  • To identify novel phage-encoded gene products that inhibit the growth of Mycobacterium smegmatis.

Main Methods:

  • Generated a library of 94 Hammy phage genes for plasmid-based overexpression.
  • Performed a plate-based cytotoxicity assay to screen for growth inhibition of Mycobacterium smegmatis.
  • Identified gene products modulating host bacterial growth.

Main Results:

  • Identified 24 out of 94 (approximately 25%) Hammy phage genes whose products inhibit Mycobacterium smegmatis growth.
  • Found that half of the identified inhibitors are conserved with those from related phage Waterfoul.
  • Discovered novel antimycobacterial growth inhibitors encoded by the Hammy phage.

Conclusions:

  • Systematic overexpression screens are effective for exploring phage genome-wide gene function.
  • Phages encode a significant number of novel antimycobacterial agents with potential therapeutic applications.
  • This study expands the known repertoire of phage-derived antimycobacterial compounds.